Perinatal Group B Streptococcal Disease Prevention, Minnesota

In 2002, revised guidelines for preventing perinatal group B streptococcal disease were published. In 2002, all Minnesota providers surveyed reported using a prevention policy. Most screen vaginal and rectal specimens at 34–37 weeks of gestation. The use of screening-based methods has increased dram...

Descripción completa

Detalles Bibliográficos
Autores principales: Morin, Craig A., White, Karen, Schuchat, Anne, Danila, Richard N., Lynfield, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2005
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310609/
https://www.ncbi.nlm.nih.gov/pubmed/16229785
http://dx.doi.org/10.3201/eid1109.041109
_version_ 1782227667806846976
author Morin, Craig A.
White, Karen
Schuchat, Anne
Danila, Richard N.
Lynfield, Ruth
author_facet Morin, Craig A.
White, Karen
Schuchat, Anne
Danila, Richard N.
Lynfield, Ruth
author_sort Morin, Craig A.
collection PubMed
description In 2002, revised guidelines for preventing perinatal group B streptococcal disease were published. In 2002, all Minnesota providers surveyed reported using a prevention policy. Most screen vaginal and rectal specimens at 34–37 weeks of gestation. The use of screening-based methods has increased dramatically since 1998.
format Online
Article
Text
id pubmed-3310609
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-33106092012-04-06 Perinatal Group B Streptococcal Disease Prevention, Minnesota Morin, Craig A. White, Karen Schuchat, Anne Danila, Richard N. Lynfield, Ruth Emerg Infect Dis Dispatch In 2002, revised guidelines for preventing perinatal group B streptococcal disease were published. In 2002, all Minnesota providers surveyed reported using a prevention policy. Most screen vaginal and rectal specimens at 34–37 weeks of gestation. The use of screening-based methods has increased dramatically since 1998. Centers for Disease Control and Prevention 2005-09 /pmc/articles/PMC3310609/ /pubmed/16229785 http://dx.doi.org/10.3201/eid1109.041109 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Morin, Craig A.
White, Karen
Schuchat, Anne
Danila, Richard N.
Lynfield, Ruth
Perinatal Group B Streptococcal Disease Prevention, Minnesota
title Perinatal Group B Streptococcal Disease Prevention, Minnesota
title_full Perinatal Group B Streptococcal Disease Prevention, Minnesota
title_fullStr Perinatal Group B Streptococcal Disease Prevention, Minnesota
title_full_unstemmed Perinatal Group B Streptococcal Disease Prevention, Minnesota
title_short Perinatal Group B Streptococcal Disease Prevention, Minnesota
title_sort perinatal group b streptococcal disease prevention, minnesota
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310609/
https://www.ncbi.nlm.nih.gov/pubmed/16229785
http://dx.doi.org/10.3201/eid1109.041109
work_keys_str_mv AT morincraiga perinatalgroupbstreptococcaldiseasepreventionminnesota
AT whitekaren perinatalgroupbstreptococcaldiseasepreventionminnesota
AT schuchatanne perinatalgroupbstreptococcaldiseasepreventionminnesota
AT danilarichardn perinatalgroupbstreptococcaldiseasepreventionminnesota
AT lynfieldruth perinatalgroupbstreptococcaldiseasepreventionminnesota

Ejemplares similares